Navi
Right
 
Skip Navigation LinksHome Research report list Pharma & Healthcare Healthcare Global Endovascular Aneurysm Repair (EVAR) Market Report: 2015 Edition
 
Social
Global Endovascular Aneurysm Repair (EVAR) Market Report: 2015 Edition
Format : Pdf (Instant Download)
Date: 15, January 2016 | Pages: 52
Social
 
Electronic Access - Single User License
Tool
USD 800
Electronic Access - Corporate User License
Tool
USD 1100
Hard Copy - Mail Delivery
Tool
USD 875
 
   
 

An abdominal aortic aneurysm (AAA) is a localized bulging or abnormal enlargement of the abdominal aorta (the largest artery in the human body), most often the infrarenal and aorto-iliac arteries. AAAs occur most often in Caucasian males over the age of 65 years; they are less common in women.


Endovascular aneurysm repair (EVAR) is a minimally invasive alternative to major open surgery for the repair of AAA’s that results in reduced recovery times and potentially improved survival rates. It is a type of endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA). Endovascular procedures aim to reduce the morbidity and mortality of treating arterial disease in a patient population that is increasingly older and less fit than when major open repairs were developed and popularized.


Growing numbers of geriatric population and associated expenditure for health care, steadily increasing cases of AAA screening worldwide are likely to fuel growth over the coming years. Postoperative complications like Endoleaks and migration is the biggest challenge faced by the industry. Also the growing number of regulations posed by regulatory authorities like FDA restricts the industry players. Some of the trends impacting the market include ongoing clinical studies, growing use of percutaneous EVAR, preferences for various AAA repair methods, and technological developments.


This report assesses the global EVAR market in terms of both market volume and market value on the global and regional level. The increasing competition in the EVAR industry has been analyzed on a variety of factors: revenue, surgical outcomes, postoperative procedures and complications. The top three companies having a vicious competition with each other and dominating the EVAR industry are- Medtronic, TriVascular and Lombard Medical. These players are being profiled in the report along with their key financials and strategies for growth. 

 

1. Abdominal Aortic Aneurysm (AAA)


1.1 Overview


1.1.1 Signs & Symptoms
1.1.2 Diagnosis
1.1.3 Management


1.2 Global Market Analysis
-Market Penetration
-Market Segmentation


1.3 Regional Market Comparison


1.3.1 On the Basis of Diagnosed Cases & Procedures Performed
-United States
-Europe


1.3.2 On the Basis of Prevalence by Gender
-United States
-Europe


1.3.3 On the Basis of Prevalence by Population
-United States
-Europe


1.3.4 On the Basis of Procedure Mix
-United States
-Europe


2. Endovascular Aneurysm Repair (EVAR)


2.1 Overview


2.1.1 Medical Applications
2.1.2 Adjunctive Procedures
2.1.3 Techniques
2.1.4 Complications


2.2 Global Market Analysis
-Market Value (Actual & Forecasted)
-Regional Breakdown (Actual & Forecasted)
-Price Trend of Market Segments


2.3 Regional Markets


2.3.1 The US
-Market Value
-Procedure Share


2.3.2 Europe
-Market Value
-Procedure Share


2.3.3 Rest of the World
-Market Value
-Procedure Share


3. Market Dynamics


3.1 Growth Drivers


3.1.1 Ageing Population
3.1.2 Increased AAA screening
3.1.3 Suitability with Age Groups
3.2.4 Rising Healthcare Expenditure


3.2 Key Trends and Developments


3.2.1 Clinical Studies & Publications
3.2.2 Growing Adoption for PEVAR
3.2.3 Procedural Characteristics
3.2.4 Technological Developments


3.3 Challenges


3.3.1 Rising Chances of Endoleaks
3.3.2 Stringent Regulations


4. Competitive Landscape
-Competitive Overview
-Market Share
-Market Opportunity
-Competitor Comparison


5. Company Profiles


5.1 Medtronic Inc. (Endurant)


5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies


5.2 TriVascular (Ovation Xi)


5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies


5.3 Lombard Medical (Aorfix)


5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies 

List of Charts


AAA Market by Penetration (2015)
AAA Market Segmentation by Patient Anatomy (2014)
The US AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)
European AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)
The US AAA Prevalence Model by Gender (2014-2020E)
European AAA Prevalence Model by Gender (2014-2020E)
The US AAA Prevalence Model by Population (2014-2020E)
European AAA Prevalence Model by Population (2014-2020E)
The US AAA Market by Procedure Mix (2014-2020E)
European AAA Market by Procedure Mix (2014-2020E)
Global EVAR Market by Value - Actual (2010-2015E)
Global EVAR Market by Value - Forecast (2016F-2020F)
Global EVAR Market by Region - Actual (2010-2015E)
Global EVAR Market by Region - Forecast (2016F-2020F)
Regional EVAR Market Value YoY Change (2011-2020F)
Regional EVAR Market Segment by Average Selling Price (2014-2020E)
The US EVAR Market by Value (2014-2020E)
The US EVAR Market by Procedure Mix (2014-2020E)
European EVAR Market by Value (2014-2020E)
European EVAR Market by Procedure Mix (2014-2020E)
EVAR Market by Value, ROW (2014-2020E) Figure 2.12: EVAR Market by Procedure Mix, ROW (2015E)
Global Ageing Population (2009-2014)
Suitability of Endovascular Repair with Current Stent Grafts for AAA in Korean patients (2015)
Global Healthcare Expenditure (2007-2014)
EVAR Articles in the Vascular Surgery based Publications (1990-2014E)
PEVAR Market Share in the Total EVAR Procedures (2014-2016)
PEVAR Market Opportunity
On the basis of Procedural Preference
Secondary Interventions after EVAR (2014)
Prevalence of Endoleaks & Rates of Intervention
EVAR Device Mix Market Opportunity (2015-2020)
EVAR Device Market Share by Manufacturer (2015)
Competition on Basis of Minimum Post Procedural Complications
Medtronic Sales by Business Segment (FY2015)
Medtronic’s Net Sales and Net Income (2011-2015)
TriVascular Sales by Region (2014-2015)
TriVascular Sales and Net Loss (2012-2018E)
Lombard Sales by Region (2014)
Lombard Sales and Net Loss (2012-2018E)


List of Tables


Prevalence of AAA 3.0 cm or larger in the age group 50-79 years
On The Basis of Patient Characteristics
On the basis of Surgical Outcomes, Postoperative Outcome & Complications
AAA Devices Market
ELGX Nellix vs. MDT’s Endurant and WL Gore’s Excluder Grafts Comparison
Factors Driving & Preventing Adoption of New EVAR Devices 

1. Abdominal Aortic Aneurysm (AAA)
Pages : 9
USD 300

1.1 Overview


1.1.1 Signs & Symptoms
1.1.2 Diagnosis
1.1.3 Management


1.2 Global Market Analysis
-Market Penetration
-Market Segmentation


1.3 Regional Market Comparison


1.3.1 On the Basis of Diagnosed Cases & Procedures Performed
-United States
-Europe


1.3.2 On the Basis of Prevalence by Gender
-United States
-Europe


1.3.3 On the Basis of Prevalence by Population
-United States
-Europe


1.3.4 On the Basis of Procedure Mix
-United States
-Europe


Figure 1.1: AAA Market by Penetration (2015)
Figure 1.2: AAA Market Segmentation by Patient Anatomy (2014)
Figure 1.3: The US AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)
Figure 1.4: European AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)
Figure 1.5: The US AAA Prevalence Model by Gender (2014-2020E)
Figure 1.6: European AAA Prevalence Model by Gender (2014-2020E)
Figure 1.7: The US AAA Prevalence Model by Population (2014-2020E)
Figure 1.8: European AAA Prevalence Model by Population (2014-2020E)
Figure 1.9: The US AAA Market by Procedure Mix (2014-2020E)
Figure 1.10: European AAA Market by Procedure Mix (2014-2020E) 

 
2. Endovascular Aneurysm Repair (EVAR)
Pages : 11
USD 400

2.1 Overview


2.1.1 Medical Applications
2.1.2 Adjunctive Procedures
2.1.3 Techniques
2.1.4 Complications


2.2 Global Market Analysis
-Market Value (Actual & Forecasted)
-Regional Breakdown (Actual & Forecasted)
-Price Trend of Market Segments


2.3 Regional Markets


2.3.1 The US
-Market Value
-Procedure Share


2.3.2 Europe
-Market Value
-Procedure Share


2.3.3 Rest of the World
-Market Value
-Procedure Share


Figure 2.1: Global EVAR Market by Value - Actual (2010-2015E)
Figure 2.2: Global EVAR Market by Value - Forecast (2016F-2020F)
Figure 2.3: Global EVAR Market by Region - Actual (2010-2015E)
Figure 2.4: Global EVAR Market by Region - Forecast (2016F-2020F)
Figure 2.5: Regional EVAR Market Value YoY Change (2011-2020F)
Figure 2.6: Regional EVAR Market Segment by Average Selling Price (2014-2020E)
Figure 2.7: The US EVAR Market by Value (2014-2020E)
Figure 2.8: The US EVAR Market by Procedure Mix (2014-2020E)
Figure 2.9: European EVAR Market by Value (2014-2020E)
Figure 2.10: European EVAR Market by Procedure Mix (2014-2020E)
Figure 2.11: EVAR Market by Value, ROW (2014-2020E) Figure 2.12: EVAR Market by Procedure Mix, ROW (2015E) 

 
3. Market Dynamics
Pages : 11
USD 400

3.1 Growth Drivers


3.1.1 Ageing Population
3.1.2 Increased AAA screening
3.1.3 Suitability with Age Groups
3.2.4 Rising Healthcare Expenditure


3.2 Key Trends and Developments


3.2.1 Clinical Studies & Publications
3.2.2 Growing Adoption for PEVAR
3.2.3 Procedural Characteristics
3.2.4 Technological Developments


3.3 Challenges


3.3.1 Rising Chances of Endoleaks
3.3.2 Stringent Regulations


Figure 3.1: Global Ageing Population (2009-2014)
Figure 3.2: Suitability of Endovascular Repair with Current Stent Grafts for AAA in Korean patients (2015)
Figure 3.3: Global Healthcare Expenditure (2007-2014)
Figure 3.4: EVAR Articles in the Vascular Surgery based Publications (1990-2014E)
Figure 3.5: PEVAR Market Share in the Total EVAR Procedures (2014-2016)
Figure 3.6: PEVAR Market Opportunity
Figure 3.7: On the basis of Procedural Preference
Figure 3.8: Secondary Interventions after EVAR (2014)
Figure 3.9: Prevalence of Endoleaks & Rates of Intervention


Table 3.1: Prevalence of AAA 3.0 cm or larger in the age group 50-79 years
Table 3.2: On The Basis of Patient Characteristics
Table 3.3: On the basis of Surgical Outcomes, Postoperative Outcome & Complications 

 
4. Competitive Landscape
Pages : 5
USD 200

-Competitive Overview
-Market Share
-Market Opportunity
-Competitor Comparison


Figure 4.1: EVAR Device Mix Market Opportunity (2015-2020)
Figure 4.2: EVAR Device Market Share by Manufacturer (2015)
Figure 4.3: Competition on Basis of Minimum Post Procedural Complications


Table 4.1: AAA Devices Market
Table 4.2: ELGX Nellix vs. MDT’s Endurant and WL Gore’s Excluder Grafts Comparison
Table 4.3: Factors Driving & Preventing Adoption of New EVAR Devices 

 
5. Company Profiles
Pages : 10
USD 300

5.1 Medtronic Inc. (Endurant)


5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies


5.2 TriVascular (Ovation Xi)


5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies


5.3 Lombard Medical (Aorfix)


5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies


Figure 5.1: Medtronic Sales by Business Segment (FY2015)
Figure 5.2: Medtronic’s Net Sales and Net Income (2011-2015)
Figure 5.3: TriVascular Sales by Region (2014-2015)
Figure 5.4: TriVascular Sales and Net Loss (2012-2018E)
Figure 5.5: Lombard Sales by Region (2014)
Figure 5.6: Lombard Sales and Net Loss (2012-2018E) 

 
 
 
About Us    |    PRESS RELEASES    |    RESEARCH REPORTS    |    Contact Us    |    PRIVACY POLICY    |    REFUND POLICY
@ Copyright 2014 Koncept Analytics Pvt Ltd. All Rights Reserved. Web Developed By Vision IT Consultants Pvt Ltd.